These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6762860)

  • 21. Growth regulation by estradiol, progesterone and recombinant human epidermal growth factor of human breast carcinoma xenografts grown serially in nude mice.
    Kubota T; Josui K; Fukutomi T; Kitajima M
    Anticancer Res; 1995; 15(4):1275-8. PubMed ID: 7654008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
    Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K
    Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experimental and clinical study on endocrine therapy of breast carcinoma, with special reference to the nuclear estrogen receptor].
    Kubouchi K
    Nihon Geka Gakkai Zasshi; 1984 Nov; 85(11):1405-17. PubMed ID: 6521721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.
    Jansson AK; Gunnarsson C; Cohen M; Sivik T; Stål O
    Cancer Res; 2006 Dec; 66(23):11471-7. PubMed ID: 17145895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An improved assay for nuclear estrogen receptor in experimental and human breast cancer.
    Garola RE; McGuire WL
    Cancer Res; 1977 Sep; 37(9):3333-7. PubMed ID: 884677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of the interaction between different forms of estrogen receptors and cell nuclei].
    Mataradze GD; Gontar' EV; Kondrat'ev IaIu; Rozen VB
    Biokhimiia; 1982 May; 47(5):869-78. PubMed ID: 7093387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen receptor determination in endometrial carcinoma: ligand binding assay versus enzyme immunoassay.
    Nyholm HC; Nielsen AL; Lyndrup J; Greene GL; Thorpe SM
    Anticancer Res; 1995; 15(2):649-54. PubMed ID: 7763051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple nuclear binding sites.
    Syne JS; Markaverich BM; Clark JH; Panko WB
    Cancer Res; 1982 Nov; 42(11):4449-54. PubMed ID: 7127287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra nuclear estrogen receptor status and its clinicopathological correlation in breast cancer patients.
    Khanna HD; Singh S; Agrawal G; Khanna R; Singh LP; Khanna R; Khanna S
    Cancer Biochem Biophys; 1996 Apr; 15(3):141-9. PubMed ID: 8937738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on the mechanism of the estrogen action in human breast cancer].
    Kimura M; Nishimura R; Akagi M
    Gan No Rinsho; 1985 Mar; 31(3):263-7. PubMed ID: 3999388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen binding sites in the nucleus of normal and malignant human tissue: optimization of an exchange assay for the measurement of specific binding.
    Syne JS; Markaverich BM; Clark JH; Panko WB
    Cancer Res; 1982 Nov; 42(11):4443-8. PubMed ID: 7127286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term survival in primary breast cancer: correlation with estrogen and progesterone receptor assay results and adjuvant tamoxifen therapy.
    Chrapusta SJ; Giermek J; Pieńkowski T
    Med Sci Monit; 2004 Oct; 10(10):CR577-86. PubMed ID: 15448598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is triple negative a prognostic factor in breast cancer?
    Nishimura R; Arima N
    Breast Cancer; 2008; 15(4):303-8. PubMed ID: 18369692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of 17beta-estradiol during receptor-mediated nuclear migration in breast cancer cells.
    Brooks SC; Locke ER; Horn L
    Cancer Res; 1978 Nov; 38(11 Pt 2):4238-42. PubMed ID: 698963
    [No Abstract]   [Full Text] [Related]  

  • 35. Dehydroepiandrosterone and androst-5-ene-3 beta,17 beta-diol in human mammary cancer cytosolic and nuclear compartments and their relationship to estrogen receptor.
    Adams JB; Archibald L; Seymour-Munn K
    Cancer Res; 1980 Oct; 40(10):3815-20. PubMed ID: 6449285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
    Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
    J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estradiol and progesterone receptors in human breast fibroadenomas.
    Kuttenn F; Fournier S; Durand JC; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1225-9. PubMed ID: 7229001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Endocrine differences between patients with luteal phase deficiency and inadequate endometrial response].
    Xu M; Zhang Z; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):141-4. PubMed ID: 9596886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific estrogen receptor binding and biological effects of 16 alpha-iodoestradiol on human breast cancer cells.
    Lippman ME; Do HM; Hochberg RB
    Cancer Res; 1981 Aug; 41(8):3150-4. PubMed ID: 7248972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroid receptor forms and their interaction with cytoplasmic modulators.
    Sato B; Nishizawa Y; Maeda Y; Noma K; Honma T; Matsumoto K
    J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.